Discover key takeaways from Teladoc Health's Q2 2025 earnings, including strong Integrated Care growth, BetterHelp challenges, and advancements in ...

Gain key insights into Qorvo's Q1 2026 performance: revenue growth, strategic fab closures, expanded defense content, margin improvement, and ...

Good morning, and welcome to PotlatchDeltic's Second Quarter 2025 Earnings Conference Call. Joining me on the call is Eric Cremers, PotlatchDeltic's President and Chief Executive Officer.

Discover AtriCure's standout Q2 2025 performance with 17% revenue growth, boosted by product innovation and international expansion.

Discover NMI Holdings' Q2 2025 performance: record $214.7B insured portfolio, disciplined risk management, and strong shareholder returns.

PayPal Holdings, Inc. reported a Q2 FY 2025 beat, but PYPL stock dropped 9%. Revenue growth from Braintree is reaccelerating, ...

AstraZeneca PLC ( NASDAQ: AZN) Q2 2025 Earnings Conference Call July 29, 2025 9:00 AM ET ...

Gain insights into COPT Defense Properties' Q2 2025 performance: raised outlooks, robust occupancy, and the impact of record defense spending.

Actuate Therapeutics' elraglusib shows promise in metastatic pancreatic cancer. Upcoming FDA meeting may accelerate approval.

Excelerate Energy raised guidance for full-year adjusted EBITDA to reflect the acquisition of New Fortress Energy's business ...

Hold on iShares 1-3 Year Treasury Bond ETF as short-term rates stay steady. Click to explore SHY and its potential role in ...

AIG’s baby bond (CRBD) offers a 6.89% yield to maturity, with solid credit ratings and attractive income potential compared ...